Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-04-01 | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C
(Chief Discovery/Trans Medicine) |
S | Common Stock | D | 6000 | $28.03 - $28.03 | $168,180 |
| 2024-03-18 | ARROWHEAD PHARMACEUTICALS, INC. | Lu Hongbo
(Director) |
P | Common Stock | A | 3000 | $27.49 - $28.00 | $82,990 |
| 2024-03-06 | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kennet...
(Chief Financial Officer) |
S | Common Stock | D | 40000 | $35.19 - $35.19 | $1,407,600 |
| 2024-01-31 | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christop...
(Chief Executive Officer) |
S | Common Stock | D | 57499 | $32.16 - $32.71 | $1,860,019 |
| 2024-01-31 | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christop...
(Chief Executive Officer) |
M | Common Stock | A | 57499 | $14.54 - $14.54 | $836,035 |
| 2024-01-12 | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C
(Chief Discovery/Trans Medicine) |
S | Common Stock | D | 7940 | $36.47 - $37.37 | $292,902 |
| 2024-01-11 | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN DOUGLAS B
(Director) |
S | Common Stock | D | 2911 | $37.76 - $38.55 | $110,788 |
| 2024-01-11 | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D.
(Director) |
S | Common Stock | D | 3934 | $37.81 - $38.59 | $149,758 |
| 2024-01-11 | ARROWHEAD PHARMACEUTICALS, INC. | Ferrari Mauro
(Director) |
S | Common Stock | D | 3147 | $37.80 - $38.63 | $119,786 |
| 2024-01-11 | ARROWHEAD PHARMACEUTICALS, INC. | Vakiener Victoria
(Director) |
S | Common Stock | D | 4720 | $37.87 - $38.84 | $179,813 |
| 2024-01-05 | ARROWHEAD PHARMACEUTICALS, INC. | Oliver Tracie
(Chief Commercial Officer) |
S | Common Stock | D | 74 | $33.89 - $33.89 | $2,507 |
| 2024-01-04 | ARROWHEAD PHARMACEUTICALS, INC. | Oliver Tracie
(Chief Commercial Officer) |
A | Common Stock | A | 75000 | $0.00 - $0.00 | $0 |
| 2024-01-05 | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kennet...
(Chief Financial Officer) |
S | Common Stock | D | 16104 | $34.04 - $35.65 | $567,909 |
| 2024-01-04 | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kennet...
(Chief Financial Officer) |
A | Common Stock | A | 75000 | $0.00 - $0.00 | $0 |
| 2024-01-05 | ARROWHEAD PHARMACEUTICALS, INC. | San Martin Javier
(Chief Medical Officer) |
S | Common Stock | D | 8303 | $34.11 - $35.64 | $292,803 |
| 2024-01-04 | ARROWHEAD PHARMACEUTICALS, INC. | San Martin Javier
(Chief Medical Officer) |
A | Common Stock | A | 75000 | $0.00 - $0.00 | $0 |
| 2024-01-02 | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christop...
(Chief Executive Officer) |
S | Common Stock | D | 9952 | $30.74 - $31.25 | $308,636 |
| 2023-12-15 | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D.
(Director) |
A | Common Stock | A | 14987 | $25.41 - $25.41 | $380,819 |
| 2023-11-20 | ARROWHEAD PHARMACEUTICALS, INC. | San Martin Javier
(Chief Medical Officer) |
S | Common Stock | D | 19700 | $28.73 - $29.00 | $567,315 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |